Events

EIT Food's 1st Northern European “4 per 1000” Regional Meeting
JUN
Tue
06
JUN
Wed
07
JUN
Thu
08

This was 2 years ago

Location

Hilton Helsinki - Kalastajantorppa

Hilton Helsinki Kalastajantorppa, Kalastajatorpantie 1, Helsinki, 00330 (Finland)
Programmes
Missions

The above mentioned event is organised by Baltic Sea Action Group in collaboration with the "4 per 1000" Initiative. Join the Northern European colleagues in Helsinki, Finland for new perspectives and new partners in scaling up regenerative agriculture! 

This above metioned meeting aims to connects real-world farming, policy, research, and business.

The participation is free of charge, however, the organisers reserve the right to charge no-shows with the costs incurred (approx. 150 € per day).

More detailed information, the full agenda with the speakers and the possibility to register can be found by clicking here.

Source: EIT page - Events

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.